James T. Rosenbaum

James T. Rosenbaum (born September 29, 1949) is an American physician-scientist who is Senior Vice President for Research at Corvus Pharmaceuticals[1] and Chief of Ophthalmology emeritus at the Legacy Devers Eye Institute, Portland, Oregon, where he held the Richard Chenoweth Chair.[2] Previously, he was Chief of Arthritis and Rheumatic Diseases at the Oregon Health & Science University where he held the Edward E Rosenbaum Professorship in Inflammation Research.[3] Rosenbaum was the only practicing rheumatologist/non-ophthalmologist in the world to serve as a chief of ophthalmology. He is recognized for his description of an animal model of uveitis (inflammation inside the eye) resulting from injection of bacterial endotoxin (Nature, 286:611, 1980) and for more than 600 scholarly publications, mostly related to the intersection between rheumatology and ophthalmology.[4] He is a co-author of the book, "The Clinical Neurology of Rheumatic Diseases".[5]

  1. ^ "Leadership". Corvus Pharmaceuticals. Retrieved 2023-05-14.
  2. ^ "James T. Rosenbaum MD". Legacyhealth.org. Retrieved 2013-11-06.
  3. ^ "James T. Rosenbaum, M.D. | Arthritis & Rheumatic Diseases (Adult) | OHSU". Ohsu.edu. Archived from the original on 2013-11-07. Retrieved 2013-11-06.
  4. ^ Nature Reviews Rheumatology (May 2012). "About the authors : Spondyloarthritis: The eyes have it: uveitis in patients with spondyloarthritis : Nature Reviews Rheumatology". Nature Reviews Rheumatology. 8 (5). Nature.com: 249–250. doi:10.1038/nrrheum.2012.43. PMC 3343203. PMID 22469907.
  5. ^ Lahita, Robert G. (1997). "Book Review Clinical Neurology of Rheumatic Diseases by Richard B. Rosenbaum, Stephen M. Campbell, and James T. Rosenbaum. 436 pp. Illustrated. Boston, Butterworth–Heinemann, 1996. $95. 0-7506-9613-3". New England Journal of Medicine. 336 (19): 1397. doi:10.1056/NEJM199705083361922.